345 Park Avenue South

Cure by Deerfield Launches Middle East Health Accelerator in Qatar Image

Blue

News & Insights

Your Home in NYC

Cure Founders Pass Membership Benefits 03 Tab Bar Image

Dark Blue

Become a Member

Cure Presents: The X Factor Healthcare Innovation Summit

Magenta

Events

Accelerating Advances in Health

Green

About

Contact us

Leah Rosenbaum is an experienced writer, reporter, and editor with more than seven years of experience in health and medical journalism, including as Senior Editor for Health at *Business Insider* and Assistant Editor for Healthcare and Science at *Forbes*. She earned her BA from Johns Hopkins University and a master's degree in journalism and public health from University of California, Berkeley.  

After a career championing entrepreneurs and science policy at BIO, E. Cartier Esham, PhD, launched her own firm to help healthcare innovators navigate Washington, DC, and shape the future of medicine

From Bench Scientist to Policy Powerhouse: E. Cartier Esham’s Entrepreneurial Pivot

CEO Marissa Fayer draws on her engineering background to lead DeepLook Medical and advises women’s health startups to think big, stay strategic, and seek broader investor support.

Women’s Health CEO Shares Advice on Raising Funds: Be Direct

Targeted investments in overlooked areas of women’s health could unlock massive financial and societal returns.

5 Smart Investments  for the Future of Women’s Health

Tia Health is reshaping women’s healthcare experiences with primary care in-person clinics that offer collaborative, holistic patient-centric approach.

thumbnail_tia_ceo_felicity_yost_image

How Tia Stays Competitive in a Crowded Healthcare Landscape

Former FDA Commissioner Margaret Hamburg, MD, warns that restricting global partnerships in biomedical research, public health and healthcare policy could weaken the U.S. industry.

Why Margaret Hamburg says Healthcare Needs to Stay Global  

Yael Weiss, MD, PhD, founder and CEO of Mahzi Therapeutics, shares her path to biotech leadership, offering insights on navigating the male-dominated industry and championing patient-centered innovation.

Mahzi Therapeutics CEO's Advice for Biotech Female Founders

Former FDA Commissioner Margaret Hamburg, MD, discusses the impact of federal layoffs, the erosion of public trust in science, and the risks of undermining U.S. leadership in biomedical research. 


Federal Layoffs Deeply Concern Former FDA Commissioner image

Federal Layoffs Deeply Concern Former FDA Commissioner

Mahzi Therapeutics bridges the gap between patient advocates and researchers, accelerating the development of treatments for rare genetic neurodevelopmental disorders.

How Mahzi Therapeutics Unites with Patients for Rare Disease image

How Mahzi Therapeutics Unites with Patients for Rare Disease

CIF, part of a growing sector of venture funds that invest for social good, is a non-profit that practices regenerative philanthropy.


Catalytic Impact Foundation Funds Action in Women’s Health image

CIF Funds Action in Women’s Health 

AHA’s President Elect Stacey E Rosen, MD, FAHA, urges women to take charge of their heart health.

Women and Heart Disease: The Overlooked Health Crisis

To understand GLP-1s use for weight loss, CURE surveyed current and former patients about their attitudes and experience.

Patients Use GLP-1 Drugs for Weight Loss, Gaining Benefits

thumbnail_GLP1RA_patients_survey_GTY2025837217

Patients' Use GLP-1 Drugs for Weight Loss, Benefit Gains

To understand current prescribing practices for off-label use of GLP-1Rs, CURE surveyed physicians across the specialties of gastroenterology, addiction medicine, cardiology, neurology and orthopedics.

Specialty Physicians on Using GLP-1 Drugs Off Label 

National Academies’ groundbreaking report calls for $15.7 billion in Congressional funding to foster interdisciplinary women’s health research and scientific careers.

NIH Recommended to Create New Institute for Women’s Health 

thumbnail_white_paper_non-invasive_prenatal_testing_ver02

Consensus and Controversy: Clinicians’ Views of Non-Invasive Prenatal Testing 

Explore the candid opinions of endocrinologists on GLP-1 drugs like Ozempic and Mounjaro. Uncover their thoughts on efficacy, patient satisfaction and the future landscape of these groundbreaking treatments in our white paper.

White Paper GLP-1

What Doctors Really Think of GLP-1 Medications

Sickle Cells

The Promises and Perils of Gene Editing for Sickle Cell

image top-view-hand-holding-pregnancy-test

Patient Engagement Is the Secret to Smarter Research—Here’s How to Nail It

Meet the 15 Startups Joining Cure’s Middle East Health Accelerator

Your Home in NYC

November 11 -13 , 2025

Cure Presents: The X Factor Healthcare Innovation Summit

Accelerating Advances in Health

Leah Rosenbaum

17 Articles by Leah Rosenbaum